Radiotherapy Quality: From Reactive Management to Proactive Improvement
"How a French Radiotherapy Group Enhanced Quality Management with Dynamic Strategies and Digital Tools"
In the ever-evolving landscape of healthcare, ensuring the highest standards of quality and safety in treatments is paramount. Radiotherapy, a critical component in cancer care, demands rigorous quality management systems. Since the publication of the international standard NF EN ISO 9000 in 2000, healthcare facilities providing care have been urged to make available a quality management system. This framework is designed to safeguard the safety and quality of treatments. This is further reinforced by Article L. 6113-3 of the Public Health Code (revised in 2010), which mandates the continuous improvement of healthcare quality for patients.
Regulatory bodies such as Regional Health Agencies (ARS), the Nuclear Safety Authority (ASN), and the High Authority for Health (HAS) rely on these standards to ensure compliance during inspections. Early on, the Groupement de Radiothérapie et d'Oncologie des Pyrénées (GROP) proactively developed its quality system to align with these recommendations and meet the requirements set forth by these governing bodies.
The GROP, consisting of two facilities in Pau and Tarbes, France, focuses on providing radiotherapy and curietherapy treatments. Recognizing the importance of a unified approach, GROP has been committed to standardizing its practices across both locations, with a strong emphasis on teamwork and consistent application. This commitment aims to improve efficiency and service quality, ultimately supporting the best possible results for every patient.
Quality Improvement in Practice
AHRQ’s Quality Indicators program describes its focus as supporting healthcare decision-making, quality improvement, and research. A 2020 review reports that radiation therapy management teams interrogate and report incident data, identify root causes, and share findings at monthly multidisciplinary incident review meetings to educate staff. A 2025 international review names quality deficits including low uptake of short-course radiation for bone metastases, inadequate radiation oncology referral after prostatectomy, increased malnutrition during head and neck radiotherapy, and poor symptom management during prostate radiotherapy.
Quality Management Infrastructure
A radiotherapy group’s move from quality management toward dynamic management through quality proposed involving process drivers and investing material and financial resources in document-management software. The source reports that implementing these organizational and managerial provisions enabled the group to better meet ISO 9001 requirements, described as the international reference in quality management. The snippet does not specify the limitations of this approach.
Embracing Dynamic Quality Management: A Strategic Shift
In 2015, the GROP embarked on a journey to evolve its quality management system from a traditional, reactive approach to a dynamic, proactive model. This shift was driven by the need for continuous optimization and a desire to enhance the effectiveness of the existing quality framework. The team identified two key areas for improvement:
- Enhanced ownership and accountability among staff.
- More effective implementation of quality standards.
- Improved identification of areas for process improvement.
Evidence Gaps in Quality Assurance
A systematic review of radiotherapy trial quality assurance found that the optimal processes were unclear and that little evidence was available. It called for improved reporting of outcomes from radiotherapy quality assurance programmes to build an evidence base for choosing an optimal approach. Separately, an international review identified only 26 quality-improvement intervention studies across a publication window of more than 20 years; all reported clinical benefits, while the authors noted past concerns about publication bias and clinicians’ reluctance to publish negative results.
Risk Assessment and Feedback
A UK-center evaluation of failure modes and effects analysis (FMEA) for routine lung-radiotherapy risk assessment reported 29.5 hours of total staff time, including 14 hours (47%) from the facilitator. A separate report on incident learning and FMEA-guided safety initiatives says care pathways have been used with greater than 97% clinical compliance. In a study of incident-driven FMEA feedback loops, 16 additional failure modes were identified, and their risk priorities did not differ from those of the initial failure modes (p = 0.954).
Key Takeaways for Healthcare Professionals
GROP's journey offers several key insights for healthcare professionals and organizations looking to enhance their own quality management systems: Empowering process drivers and investing in digital tools can drive significant improvements in quality and efficiency.
Quality Indicators and Trial Outcomes
A June 2025 systematic review and meta-analysis set out to assess the impact of radiotherapy quality assurance results in contemporary randomized controlled trials on patient outcomes. Its abstract describes radiotherapy quality assurance as important to trial validity and reproducibility, but the supplied snippet does not report the meta-analysis findings. A 2024 review notes progress in developing radiotherapy quality indicators over the past two decades, while observing that literature has focused predominantly on process- and outcome-related indicators and given limited attention to structural indicators.
Quality Across Treatment Delivery
A 2022 account discusses links between quality management in radiotherapy treatment delivery, routine maintenance and repair, and patient-specific quality-control activities. It reports that a programme applied to treatment delivery can affect individual patients as well as the quality of treatment techniques and future planning. The IAEA defines quality management as coordinated activities to direct and control radiotherapy procedures with regard to quality, with safe and effective treatment as the main aim; it also says a quality system should optimize treatments and take all possible measures to prevent inappropriate exposures.
Protocol, Workflow, and Safety Culture
The supplied source describes quality assurance practices as helping oncology trials meet an acceptable and consistent quality level by checking that trials follow protocol and that reported data are valid and reproducible. It also identifies radiotherapy’s complexity as a reason QA is integral to clinical trials involving radiation. The same supplied material describes a retrospective study evaluating workflow optimization from 2021 to 2024 using operational and clinical metrics, and lists stages from patient admission and CT/MR simulation through treatment planning, multilevel QA, and plan transfer. A 2023 publication title links process management and safety culture in radiotherapy services with quality, patient care, and safety, but the snippet provides no specific findings.
A dynamic quality management approach fosters a culture of continuous improvement, leading to better patient outcomes and greater staff engagement.
By sharing their experiences and results, GROP hopes to inspire other healthcare organizations to embrace dynamic quality management principles and embark on their own journeys toward excellence in patient care.